Bio-Rad Laboratories BIO Americas — Net Sales
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories's americas — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories's americas — net sales?
- Bio-Rad Laboratories (BIO) reported americas — net sales of $45.1M in Q1 2026.
- How has Bio-Rad Laboratories's americas — net sales changed year-over-year?
- Bio-Rad Laboratories's americas — net sales increased by 13.3% year-over-year, from $39.8M to $45.1M.
- What is the long-term trend for Bio-Rad Laboratories's americas — net sales?
- Over 4 years (2021 to 2025), Bio-Rad Laboratories's americas — net sales has grown at a 1.4% compound annual growth rate (CAGR), from $156.4M to $165.4M.
- What does americas — net sales mean?
- The total revenue earned from customers located in the Americas.
- How do you interpret americas — net sales?
- An increase suggests successful market expansion or higher demand for diagnostic and research tools in the region, while a decrease may indicate competitive pressure or economic headwinds in these specific markets.
- How does americas — net sales compare across companies?
- Peers in the life sciences and diagnostics sector typically report regional revenue splits, allowing for benchmarking against competitors with similar geographic footprints in the Americas.